Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Effects of nicotine on emotional distraction of attentional orienting: evidence of possible moderation by dopamine type 2 receptor genotype.

Hammersley JJ, Rzetelny A, Gilbert DG, Rabinovich NE, Small SL, Huggenvik JI.

Pharmacol Biochem Behav. 2013 Apr;105:199-204. doi: 10.1016/j.pbb.2013.02.017. Epub 2013 Mar 5.

2.

Dopamine receptor (DRD2) genotype-dependent effects of nicotine on attention and distraction during rapid visual information processing.

Gilbert DG, Izetelny A, Radtke R, Hammersley J, Rabinovich NE, Jameson TR, Huggenvik JI.

Nicotine Tob Res. 2005 Jun;7(3):361-79.

PMID:
16085504
3.

Emotional stimuli and context moderate effects of nicotine on specific but not global affects.

Gilbert DG, Riise H, Dillon A, Huber J, Rabinovich NE, Sugai C.

Exp Clin Psychopharmacol. 2008 Feb;16(1):33-42. doi: 10.1037/1064-1297.16.1.33.

4.

Brain indices of nicotine's effects on attentional bias to smoking and emotional pictures and to task-relevant targets.

Gilbert DG, Sugai C, Zuo Y, Rabinovich NE, McClernon FJ, Froeliger B.

Nicotine Tob Res. 2007 Mar;9(3):351-63.

PMID:
17365767
5.

Neurocognitive variation in smoking behavior and withdrawal: genetic and affective moderators.

Evans DE, Park JY, Maxfield N, Drobes DJ.

Genes Brain Behav. 2009 Feb;8(1):86-96. doi: 10.1111/j.1601-183X.2008.00445.x.

6.

Nicotine primes attention to competing affective stimuli in the context of salient alternatives.

Asgaard GL, Gilbert DG, Malpass D, Sugai C, Dillon A.

Exp Clin Psychopharmacol. 2010 Feb;18(1):51-60. doi: 10.1037/a0018516.

7.

Moderation of nicotine effects on covert orienting of attention tasks by poor placebo performance and cue validity.

Hammersley JJ, Gilbert DG, Rzetelny A, Rabinovich NE.

Pharmacol Biochem Behav. 2016 Oct;149:9-16. doi: 10.1016/j.pbb.2016.07.006. Epub 2016 Jul 25.

PMID:
27461547
8.

Nicotine differentially modulates antisaccade eye-gaze away from emotional stimuli in nonsmokers stratified by pre-task baseline performance.

Wachter NJ, Gilbert DG.

Psychopharmacology (Berl). 2013 Feb;225(3):561-8. doi: 10.1007/s00213-012-2842-6. Epub 2012 Sep 7.

9.

Modulation of nicotine effects on selective attention by DRD2 and CHRNA4 gene polymorphisms.

Ahrens S, Markett S, Breckel TP, Behler O, Reuter M, Thiel CM.

Psychopharmacology (Berl). 2015 Jul;232(13):2323-31. doi: 10.1007/s00213-015-3869-2. Epub 2015 Feb 3.

PMID:
25647695
10.

Gene and gene by sex associations with initial sensitivity to nicotine in nonsmokers.

Perkins KA, Lerman C, Coddington S, Jetton C, Karelitz JL, Wilson A, Jennings JR, Ferrell R, Bergen AW, Benowitz NL.

Behav Pharmacol. 2008 Sep;19(5-6):630-40. doi: 10.1097/FBP.0b013e32830c3621.

11.

Nicotinergic Modulation of Attention-Related Neural Activity Differentiates Polymorphisms of DRD2 and CHRNA4 Receptor Genes.

Breckel TP, Giessing C, Gieseler A, Querbach S, Reuter M, Thiel CM.

PLoS One. 2015 Jun 16;10(6):e0126460. doi: 10.1371/journal.pone.0126460. eCollection 2015.

12.

Effects of nicotine on brain responses to emotional pictures.

Gilbert DG, Sugai C, Zuo Y, Eau Claire N, McClernon FJ, Rabinovich NE, Markus T, Asgaard G, Radtke R.

Nicotine Tob Res. 2004 Dec;6(6):985-96.

PMID:
15801571
13.

Neurotransmission-related genetic polymorphisms, negative affectivity traits, and gender predict tobacco abstinence symptoms across 44 days with and without nicotine patch.

Gilbert DG, Zuo Y, Rabinovich NE, Riise H, Needham R, Huggenvik JI.

J Abnorm Psychol. 2009 May;118(2):322-34. doi: 10.1037/a0015382.

14.

Effects of nicotine and depressive traits on affective priming of lateralized emotional word identification.

Gilbert DG, Carlson JM, Riise H, Rabinovich NE, Sugai C, Froeliger B.

Exp Clin Psychopharmacol. 2008 Aug;16(4):293-300. doi: 10.1037/a0012871.

15.

Effects of nicotine on visuospatial attentional orienting in non-smokers.

Impey D, Chique-Alfonzo M, Shah D, Fisher DJ, Knott VJ.

Pharmacol Biochem Behav. 2013 May;106:1-7. doi: 10.1016/j.pbb.2013.02.015. Epub 2013 Mar 5.

PMID:
23470330
16.

Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch.

Johnstone EC, Yudkin PL, Hey K, Roberts SJ, Welch SJ, Murphy MF, Griffiths SE, Walton RT.

Pharmacogenetics. 2004 Feb;14(2):83-90.

PMID:
15077009
17.

The effects of nicotine dose expectancy and motivationally relevant distracters on vigilance.

Robinson JD, Engelmann JM, Cui Y, Versace F, Waters AJ, Gilbert DG, Gritz ER, Cinciripini PM.

Psychol Addict Behav. 2014 Sep;28(3):752-60. doi: 10.1037/a0035122. Epub 2014 May 19.

18.

Genetic variations in COMT and DRD2 modulate attentional bias for affective facial expressions.

Gong P, Shen G, Li S, Zhang G, Fang H, Lei L, Zhang P, Zhang F.

PLoS One. 2013 Dec 2;8(12):e81446. doi: 10.1371/journal.pone.0081446. eCollection 2013.

19.

Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?

David SP, Niaura R, Papandonatos GD, Shadel WG, Burkholder GJ, Britt DM, Day A, Stumpff J, Hutchison K, Murphy M, Johnstone E, Griffiths SE, Walton RT.

Nicotine Tob Res. 2003 Dec;5(6):935-42.

PMID:
14668077
20.

Dopamine system genes are associated with orienting bias among healthy individuals.

Zozulinsky P, Greenbaum L, Brande-Eilat N, Braun Y, Shalev I, Tomer R.

Neuropsychologia. 2014 Sep;62:48-54. doi: 10.1016/j.neuropsychologia.2014.07.005. Epub 2014 Jul 17.

PMID:
25038551
Items per page

Supplemental Content

Write to the Help Desk